Ignite Creation Date:
2024-05-06 @ 6:46 PM
Last Modification Date:
2024-10-26 @ 2:54 PM
Study NCT ID:
NCT05779644
Status:
RECRUITING
Last Update Posted:
2023-05-16
First Post:
2023-03-09
Brief Title:
Effects of GLP-1RA on Body Weight Metabolism and Fat Distribution in OverweightObese Patients With Type 2 Diabetes Mellitus
Sponsor:
RenJi Hospital
Organization:
RenJi Hospital
Study Overview
Official Title:
Effects of GLP-1RA on Body Weight Metabolism and Fat Distribution in OverweightObese Patients With Type 2 Diabetes Mellitus
Status:
RECRUITING
Status Verified Date:
2023-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to analyze the effects of GLP-1RA on blood glucose body weight glucose and lipid metabolism and fat distribution in overweightobese patients with type 2 diabetes mellitus
Detailed Description:
Specific research contents To study the characteristics of glucose and lipid metabolism and fat distribution in overweightobesity patients with type 2 diabetes mellitus liraglutide semaglutide metformin will be applied to patients for one year and the changes of lipid metabolism and fat distribution in overweightobese patients with type 2 diabetes and the differences among the three groups will be analyzed before and after treatment The metabolomic changes of overweightobese patients with type 2 diabetes before and after medication and the differences among the three groups will be analyzed Explore the correlation between visceral fat content glucose and lipid metabolism inflammatory factors and other biochemical indicators and metabolomics
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None